Dr. Otterson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-6529Fax+1 614-293-9469
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Rush University Medical CenterResidency, Internal Medicine, 1986 - 1989
Georgetown University School of MedicineClass of 1986
Certifications & Licensure
OH State Medical License 1998 - 2024
MD State Medical License 1989 - 1999
IL State Medical License 1986 - 1990- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACP) American College of Physicians, 2002
- Join now to see all
Clinical Trials
- Capecitabine in Treating Patients With Malignant Mesothelioma Start of enrollment: 2000 Nov 01
- Combination Chemotherapy in Treating Patients With Solid Tumors Start of enrollment: 2001 Jan 01
- Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer Start of enrollment: 2004 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 252 citationsAntitumor activity of crizotinib in lung cancers harboring a MET exon 14 alterationAlexander Drilon, Jeffrey W. Clark, Jared Weiss, Sai-Hong Ignatius Ou, D. Ross Camidge
Nature Medicine. 2020-01-13 - 168 citationsNCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.David S Ettinger, Douglas E Wood, Dara L Aisner, Wallace Akerley, Jessica R Bauman
Journal of the National Comprehensive Cancer Network. 2023-04-01 - 1126 citationsActivity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063):...Naiyer A. Rizvi, Julien Mazieres, David Planchard, Thomas E. Stinchcombe, Grace K. Dy
The Lancet. Oncology. 2015-03-01
Journal Articles
- Identifying Patterns of Care for Elderly Patients with Non-Surgically Treated Stage III Non-Small Cell Lung Cancer: An Analysis of the National Cancer DatabaseKai He, Terence M Williams, John C Grecula, Eric D Miller, Erin M Bertino, David P Carbone, Peter G Shields, Jose G Bazan, Karl E Haglund, Gregory A Otterson, BioMed Central
Press Mentions
Targeted Therapy of Lung Cancer – Lung Cancer Targeted TherapyOctober 28th, 2015
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
